Evidence map›Paper›PMID 42279434›Full record

ReviewCancers2026

Targeting Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: Rationale, Current Evidence, and a CEACAM6 CAR-T Strategy.

Marcin Piejko, Karolina Bak, Joanna Wierciak, Hanna Plutecka, Natalia Wilczynska-Zawal, Malgorzata Osmola, Kamil Rapacz, Jacek Kijowski, Patrycja Mensah-Glanowska, Antoni Szczepanik and 1 more

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marcin Piejko3rd Department of General Surgery, Jagiellonian University Medical College, 31-202 Krakow, Poland.ORCID 0000-0003-3251-5984
Karolina BakJagiellonian Center for Clinical Trial-Biobank, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Joanna WierciakJagiellonian Center for Clinical Trial-Biobank, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Hanna PluteckaDivision of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Natalia Wilczynska-ZawalJagiellonian Center for Clinical Trial-Biobank, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Malgorzata OsmolaMaria Sklodowska-Curie Medical Academy in Warsaw, 03-411 Warsaw, Poland.ORCID 0000-0001-6188-7328
Kamil RapaczJagiellonian Center for Clinical Trial-Biobank, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Jacek KijowskiCell Bank, Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Patrycja Mensah-GlanowskaDepartment of Hematology, Jagiellonian University Collegium Medicum, University Hospital in Cracow, 30-688 Krakow, Poland.ORCID 0000-0002-9850-2206
Antoni Szczepanik3rd Department of General Surgery, Jagiellonian University Medical College, 31-202 Krakow, Poland.ORCID 0000-0002-0244-7629
Marek Sierzega1st Department of Surgery, Faculty of Medicine, Jagiellonian University Medical College, 30-688 Krakow, Poland.

Funding

Agencja Badań Medycznych KPOD.07.07-IW.07-00238/24
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adoptive immunotherapyCAR-TCEACAM6circulating tumor cellsCTCsctDNAMRDPDAC

Identifiers

PMID42279434
PMCPMC13257320

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.